Alergologia Polska - Polish Journal of Allergology
eISSN: 2391-6052
ISSN: 2353-3854
Alergologia Polska - Polish Journal of Allergology
Current issue Archive Manuscripts accepted About the journal Supplements Special issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
1/2026
vol. 13
 
Share:
Share:
abstract:
Case report

Recurrent infections and immunodeficiency in a patient with Sanfilippo syndrome (MPS type 3)

Öner Özdemir
1
,
Kübra Çevik Tokmak
1

  1. Division of Allergy and Immunology, Department of Pediatrics, Research and Training Hospital of Sakarya, Sakarya University Medical Faculty, Adapazarı, Sakarya, Türkiye
Alergologia Polska – Polish Journal of Allergology 2026; 13, 1: 58–61
Online publish date: 2026/02/27
View full text Get citation
 
PlumX metrics:
Sanfilippo syndrome (mucopolysaccharidosis type III, MPS III) is a rare lysosomal storage disorder characterized by progressive neurodegeneration, behavioral abnormalities, and multisystemic involvement, with autosomal recessive inheritance. Recent findings suggest that immune system disorders may play a role in the pathogenesis and clinical complications of the disease, in addition to the classic neurological presentation. In this case, total IgG and subclass deficiencies were detected in an 18-year-old female patient who was being monitored for frequent respiratory tract infections, and intravenous immunoglobulin (IVIG) treatment was initiated with a diagnosis of humoral immunodeficiency. A significant decrease in the incidence of post-treatment infections and hospital admissions has been observed. Immune system involvement in MPS patients may increase the risk of infection. Therefore, immunological evaluation and appropriate treatment approaches are critical for improving quality of life.
keywords:

Sanfilippo syndrome, mucopolysaccharidosis type III, lysosomal storage disease, immunodeficiency, intravenous immunoglobulin therapy, respiratory tract infections, IgG subclass deficiency

FEATURED PRODUCTS
EVENTS
Webinar Testowy


Quick links
© 2026 Termedia Sp. z o.o.
Developed by Termedia.